Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: catalogue (6), inventory (20), register (219), record (571), roll (153), listing (1000)

Capecitabine-Radiotherapy

Description: Chemotherapy Protocol PANCREATIC CANCER CAPECITABINE (RADIOTHERAPY) Regimen • Pancreatic Cancer – Capecitabine (Radiotherapy) Indication • Locally advanced, non-metastatic pancreatic cancer • WHO performance status
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Capecitabine-Radiotherapy.pdf

Capecitabine-Mitomycin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-MITOMYCIN Regimen • Colorectal Cancer – Capecitabine-Mitomycin Indication • Second / third line therapy of metastatic/advanced colorectal cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin.pdf

Capecitabine-Mitomycin-Radiotherpy

Description: Chemotherapy Protocol ANAL CANCER CAPECITABINE-MITOMYCIN-RADIOTHERAPY Regimen • Anal Cancer – Capecitabine-Mitomycin-Radiotherapy Indication • Squamous cell carcinoma of the anus • WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin-Radiotherpy.pdf

Capecitabine (21 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE (21 day) Regimen • Colorectal Cancer – Capecitabine (21 day) Indication • Metastatic / advanced colorectal cancer • Adjuvant therapy of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine21day.pdf

Capecitabine (14 day)

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE (14 day) Regimen • Colorectal Cancer – Capecitabine (14 day) Indication • Metastatic / advanced colorectal cancer • Adjuvant therapy of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine14day.pdf

Neuroendocrine-Sunitinib Ver 1

Description: Chemotherapy Protocol NEUROENDOCRINE SUNITINIB Regimen Neuroendocrine - Sunitinib Indication The 1st, 2nd or 3rd line treatment of pancreatic neuroendocrine carcinomas that are
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Neuroendocrine-Sunitinib-Ver-1.pdf

Neuroendocrine-Cisplatin-Fluorouracil-Streptozocin

Description: Chemotherapy Protocol NEUROENDOCRINE CISPLATIN-FLUOROURACIL-FOLINIC ACID-STREPTOZOCIN (FCiSt) Regimen • Neuroendocrine – Cisplatin-Fluorouracil-Folinic Acid-Streptozocin (FCiST) Indication • Metastatic or locally
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Neuroendocrine-Cisplatin-Fluorouracil-Streptozocin.pdf

Temozolomide RT (7 day)

Description: Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE RT (7 day) Regimen • CNS – Temozolomide RT (7 day) Indication • First line treatment of newly
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-RT-7-day.pdf

Temozolomide (150)

Description: Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (150) Regimen • CNS – Temozolomide (150) Indication • First line treatment of newly diagnosed glioblastoma multiforma starting
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-150.pdf

Lomustine ver 1

Description: Chemotherapy Protocol Central Nervous System LOMUSTINE Regimen CNS – Lomustine Indication Adjuvant treatment for grade III gliomas including anaplastic astrocytoma, oligodendrogliomas and
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Lomustine-ver-1.pdf

421 to 430 of 1000

Previous … 41 42 43 44 45 … Next